New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base;   - solution for injection - 25 mg/ml - active: levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base   excipient: ascorbic acid sodium chloride sodium sulfite water for injection - nozinan is indicated in the management of terminal pain and accompanying restlessness or distress.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine maleate 100mg equivalent to levompromazine 74.1mg;  ;   - tablet - 100 mg - active: levomepromazine maleate 100mg equivalent to levompromazine 74.1mg     excipient: calcium carbonate macrogol 6000 polyvinyl acetate potato starch sodium laurilsulfate stearic acid - psychiatry as an alternative to largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine maleate 25mg equivalent to levomepromazine 18.5mg;  ;   - tablet - 25 mg - active: levomepromazine maleate 25mg equivalent to levomepromazine 18.5mg     excipient: calcium hydrogen phosphate dihydrate macrogol 6000 magnesium stearate polyvinyl acetate potato starch sodium laurilsulfate - psychiatry as an alternative to largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine maleate 135mg equivalent to levomepromazine 100mg;  ;   - tablet - 100 mg - active: levomepromazine maleate 135mg equivalent to levomepromazine 100mg     excipient: colloidal hydrated silica dextrin hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate titanium dioxide wheat starch - psychiatry as an alternative to largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine maleate 33.8mg equivalent to levomepromazine 25mg;  ;   - tablet - 25 mg - active: levomepromazine maleate 33.8mg equivalent to levomepromazine 25mg     excipient: colloidal hydrated silica dextrin hypromellose iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate titanium dioxide wheat starch - psychiatry as an alternative to largactil in schizophrenia, especially when it is desirable to reduce psychomotor activity.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neuraxpharm uk ltd - levomepromazine hydrochloride - solution for injection - 25mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - levomepromazine hydrochloride - solution for injection/infusion - 25 milligram(s)/millilitre - phenothiazines with aliphatic side-chain; levomepromazine

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neuraxpharm uk ltd - levomepromazine maleate - oral tablet - 25mg

Ireland - English - HPRA (Health Products Regulatory Authority)

neuraxpharm ireland limited - levomepromazine hydrochloride - solution for injection/infusion - phenothiazines with aliphatic side-chain; levomepromazine

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - levomepromazine, quantity: 25 mg - injection, solution - excipient ingredients: water for injections; sodium sulfite; sodium chloride; ascorbic acid - nozinan injection is indicated in the management of terminal pain and accompanying restlessness or distress.